November 26, 2024- SPONSORED SYMPOSIUM
Zero-contrast TAVI while using a novel full-body embolic protection system. PCR London Valves 2024 London, UK.
November 24, 2024- ABSTRACT
Nazif, T (2024 Nov 24) Complete Embolic Protection with Debris Capture and Removal in High-Risk Structural Heart Cases. PCR London Valves 2024 London, UK.
October 28, 2024- PRESS RELEASE
Emboline, Inc. Files Patent Infringement Suit Against AorticLab s.r.l. Regarding Embolic Protection Medical Device
May 17, 2024- ABSTRACT
de Brito, F (2024 May 17) TAVI in a severely calcified patient using a novel full-body embolic protection device (Case Presentation). euroPCR 2024 Paris, France.
April 4, 2024- PRESS RELEASE
Emboline Announces Acquisition of Significant Embolic Protection Intellectual Property Portfolio from SWAT Medical AB
March 12, 2024- PRESS RELEASE
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner® Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
October 26, 2023- ABSTRACT
Vora, A. (2023 Oct 23-26) Update from the PROTECT H2H Trial with Emboliner (Case Example). TCT 2023 San Francisco, CA USA.
September 16, 2023- ARTICLE
Grubman D, Ahmad Y, Leipsic JA, Blanke P, Pasupati S, Webster M, Nazif TM, Parise H, Lansky AJ (2023). Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study. Am J Cardiol. 2023 Nov 15;207:28-34. doi: 10.1016/j.amjcard.2023.08.137. Epub 2023 Sep 16. PMID: 37722198.
June 29, 2023- ABSTRACT
Greenbaum, A (2023 Jun28-Jul1) Multi-generational Performance of the Emboliner Full-Body Embolic Protection Catheter for TAVI: the Complete SafePass Experience. CSI-Frankfurt 2023 Frankfurt, Germany.
June 9, 2023- ABSTRACT
Nazif, T. (2023 Jun 7-10) Performance of the New Generation Emboliner Embolic Protection Device for TAVI: the SafePass 3 Study. TVT2023 Phoenix, AZ USA.
May 19, 2023- ABSTRACT
Lansky, A. (2023 May 18-20) Full-Body Embolic Protection During Transcatheter Aortic Valve Replacement: the Protect the Head to Head Study- A Pivotal, Randomized Study Comparing the Emboliner Embolic Protection Catheter to the Sentinel CPS. SCAI 2023, Phoenix, AZ USA.
May 19, 2023- ABSTRACT
Abizaid, A. (2023 May 16-19) Full body embolic protection during transcatheter aortic valve replacement: Emboliner Embolic Protection Device, Clinical Highlights. euroPCR 2023 Paris, France.
May 9, 2023- PRESS RELEASE
Emboline Announces First Patient Treated in IDE Study of Emboliner® Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
April 2, 2022- ARTICLE
Lansky A, White J, Stewart J, et al (2022). CLINICAL PREDICTORS OF EMBOLIC BURDEN AFTER TAVR: AN ANALYSIS OF THE SAFEPASS 2 CLINICAL STUDY. J Am Coll Cardiol. 2022 Mar, 79 (9_Supplement) 628. https://doi.org/10.1016/S0735-1097(22)01619-9
May 25, 2021- PRESS RELEASE
Emboline Raises over $55 Million in Series D Funding for Pivotal FDA Clinical Study and Market Launch of the Emboliner® Embolic Protection Catheter to Minimize Stroke Risk from TAVR
January 5, 2021- PRESS RELEASE
Emboline™ Raises Over $10 Million in Series C Funding to Fund Further Development of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk From TAVR
October 14, 2020- ABSTRACT
Pasupati, S. (2020 Oct 14-18) Clinical Performance of a Total Embolic Protection Device: Results of the Emboliner SafePass 2 Study. TCT 2020 (virtual).
October 14, 2020- ABSTRACT
Pasupati, S. (2020 Oct 14-18) Capture and Analysis of Debris Generated During TAVR — Can it Inform our Treatment Decisions and Prognoses? TCT 2020 (virtual).
January 15, 2020- PRESS RELEASE
Emboline Completes Enrollment in SafePass 2 Clinical Study of Emboliner Embolic Protection Catheter
June 5, 2018- PRESS RELEASE
Emboline, Inc. Completes Initial Human Clinical Cases with the Emboliner Embolic Protection Catheter
April 19, 2018- PRESS RELEASE
Emboline, Inc. Completes Funding of Over $10 million
October 28, 2016- PRESS RELEASE
Emboline’s “Enabling TAVI” Aortic Embolic Protection Technology Selected for Presentation at TCT 2016
September 15, 2014- PRESENTATION
The Emboline Aortic Embolic Protection Technology. Scott Russell, President and CEO, Emboline. TCT 2014.
December 2, 2013- PRESENTATION
The Emboline Aortic Embolic Protection Systems. Amir Belson, MD, Founder and CTO, Emboline. ICI 2013.
Emboline, Inc.
Santa Cruz, CA USA
Tel: +1 (831) 900-5020 • Fax: +1 (831) 900-5019
info@emboline.com
